Berman Capital Advisors’s Array Biopharma Inc ARRY Stock Holding History

Berman Capital Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-194	Closed	-$8K	–	1676
2019 Q2	$8K	Hold	194	–	–	﹤0.01%	845
2019 Q1	$4K	Hold	194	–	–	﹤0.01%	965
2018 Q4	$2K	Buy	+194	New	+$2.94K	﹤0.01%	927

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Berman Capital Advisors's ARRY Position: Q3 2019 in Review

Berman Capital Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 194 shares — an estimated $8K sold.

Berman Capital Advisors first reported a position in ARRY in Q4 2018 and held it in 3 quarters. The position peaked at $8K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Berman Capital Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Berman Capital Advisors sold 194 Array Biopharma Inc shares in Q3 2019, an estimated $8K.
Berman Capital Advisors first reported a position in Array Biopharma Inc in Q4 2018 and held it in 3 quarters.
Berman Capital Advisors's Array Biopharma Inc position peaked at $8K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Berman Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.